Best Myeloma doctors in Jerusalem: TOP 1 doctor

Compare top Myeloma doctors and prices in Israel. Find your best match here.

Get quotes from 3 top specialists in Israel

We'll hand-pick the best doctors based on your needs and budget.

Meet the experts behind this page

Medically reviewed by Fahad Mawlood

Medical Editor & Data Scientist

Top doctors

Israel

Reviews

14,000+

From real patients

Get free personalized treatment plans and choose the best option. No commitment · No payments for our services

Dina Ben-yehuda

New
34 years of experience
Location: Israel, Jerusalem
Clinic:
4.4
Hadassah Medical Center
Professor Ben-Yehuda is Head of Hematology at Hadassah Medical Center and a recognized Dean of its Medical School.
- Over 34 years of experience of experience treating malignant blood diseases including myeloma
- Trained at the prestigious Memorial Sloan-Kettering Cancer Center in New York
- Specializes in bone marrow transplantation and advanced gene therapy
- Leads research in molecular diagnostics for hematological diseases
- Holder of the Healing with the Heart Award for exceptional patient care
Read more

New

Doctor's visit

Price on request

Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.

Yan Matsiivskiy

Head of Medical Coordinator Team

4300++ patient journeys guided

3 years at Bookimed

142 patients from Israel have found their doctor through us this month

How you'll get your perfect doctor match

2 min Quiz

Tell us your goal, budget, timeline

Human Matching + AI

Our algorithm finds matches, coordinator verifies fit

Your Options Ready

Compare prices, packages, dates. Chat with your coordinator

Overwhelmed by choices?

Your personal Bookimed coordinator helps you find the perfect surgeon tailored to your needs

Supports you 24/7 at every stage
Helps match you with the doctor and handles all communication with clinics
Coordinates your travel, accommodation, and transfers

Guiding your treatment

Medically trained personal coordinators

Choosing the Right Doctor and Clinic: Insider Tips

When selecting a doctor or clinic, keep these key points in mind:

Check credentials

Verify certifications from bodies like ISAPS, JCI, or relevant medical boards

Review success rates

Choose doctors with solid experience and a proven track record in your specific treatment.

Read patient reviews

Browse Bookimed reviews from real patients to learn about their experiences.

Ensure effective communication

Pick clinics that offer language support for a smooth treatment process.

Ask about services

Confirm whether the price includes services such as accommodation, local transfers, and follow-up care to avoid hidden costs.

Bookimed Insights: Top Myeloma Specialists in Israel (2026)

Bookimed has coordinated 3 requests for Myeloma treatment in Israel, collaborating with 1 top-rated specialists. The doctors in this table are selected based on their international credentials, clinical expertise, and patient outcomes. The 2026 ranking is formed using verified data from actual patient cases and current programs from our partner clinics.

Rank	Doctor	experience	Good Fit For	What Sets Them Apart	Clinic & Location	Consultation
#1	Dina Ben-yehuda	34 years of experience	Complex myeloma & bone marrow transplant	Led the hematology department for over 20 years and pioneered gene therapy research. Dean of Hadassah Medical School and recipient of the Healing with the Heart Award.	Hadassah Medical Center Israel	Price on request

FAQ

These FAQs come from real patients seeking medical assistance through Bookimed. Answers are given by experienced medical coordinators and trusted clinic representatives.

What advanced treatment options are available in Israel for multiple myeloma?

Israel offers advanced multiple myeloma treatments including in-house developed CAR T-cell therapy, bispecific antibodies, and complex stem cell transplants. Facilities like Sheba Medical Center and Hadassah provide personalized precision medicine. These programs utilize genetic profiling to tailor targeted drug protocols for refractory cases.

Cellular therapy: Sheba Medical Center engineers CAR-T cells on-site in 10–11 days.
Novel immunotherapy: Clinics utilize bispecific antibodies like Teclistamab and Talquetamab for relapsed patients.
Advanced transplantation: Specialists perform autologous, allogeneic, and tandem transplants for high-risk myeloma.
Surgeon expertise: Dr. Abraham Avigdor at Sheba has over 35 years of oncology experience.

Bookimed Expert Insight: Israeli oncology centers like Sourasky and Sheba are unique because they perform both pediatric and adult bone marrow transplants at massive scale. Dr. Fredi Aviv has practiced at Sourasky for over 30 years, while Sheba serves nearly 2 million patients annually. This high volume allows doctors to manage complex side effects from aggressive daratumumab combinations more effectively than smaller regional centers.

Patient Consensus: Patients note that access to tandem transplants is often faster in Israel than in the US. Many suggest prioritizing bispecific antibodies over CAR-T if you have limited mobility, as the administration process is simpler.

What is the success rate of CAR-T therapy in Israeli clinics?

Israeli clinics achieve CAR-T therapy success rates between 70% and 90% for various blood cancers. Medical centers like Sheba and Hadassah report a 90% overall response rate for multiple myeloma. These results frequently exceed global averages due to advanced in-house cell manufacturing and early clinical adoption.

Multiple myeloma: Approximately 90% response rate with 50% of patients reaching deep remission.
Pediatric leukemia: Success reaches 85% to 90% in children with acute lymphoblastic leukemia.
Lymphoma outcomes: Centers report 70% response for DLBCL and 88% for follicular lymphoma.
Fast manufacturing: In-house production reduces vein-to-vein time to just 10 to 11 days.

Bookimed Expert Insight: Israeli centers like Sheba Medical Center offer a distinct advantage through point-of-care manufacturing. While commercial labs usually take 3 to 4 weeks, Sheba's in-house facility delivers cells in roughly 10 days. This speed prevents disease progression during the waiting period. Advanced specialists like Dr. Abraham Avigdor and Dr. Avichai Shimoni lead these high-volume programs with over 30 years of experience.

Patient Consensus: Patients note that while deep remissions are common, it is vital to discuss long-term durability with the medical team. People often emphasize that the faster cell processing in Israel provides significant peace of mind during the critical treatment window.

Who are the leading myeloma specialists in Israel?

Israel boasts internationally recognized myeloma specialists at JCI-accredited institutions like Sheba Medical Center and Sourasky Medical Center. These experts include Prof. Avichai Shimoni and Dr. Hila Magen, both leading figures in immunotherapy and stem cell transplantation for plasma cell disorders.

Dr. Hila Magen: Directs Sheba Medical Center's Multiple Myeloma and Amyloidosis Unit.
Prof. Avichai Shimoni: Professor at Tel Aviv University specializing in high-risk blood cancers.
Dr. Abraham Avigdor: Leads Sheba's Institute of Hematology and integrates advanced CAR-T protocols.
Dr. Ron Ram: Hematology-oncology specialist at Sourasky Medical Center performing stem cell transplants.
Prof. Moshe Gatt: Chairs the Israeli Myeloma Treatment Society at Hadassah Medical Center.

Bookimed Expert Insight: Israeli oncology centers demonstrate high-volume expertise, with Sourasky Medical Center serving 1.8 million patients and maintaining a 90% success rate. Experts like Dr. Hila Magen and Dr. Abraham Avigdor have over 30 years of experience. This deep specialization is why many specialists are listed among Forbes' Top Doctors.

Patient Consensus: Patients note the value of specialists who participate in international clinical trials. Many seek out physicians like Prof. Michael Shapira for personalized bone marrow transplant protocols.

Are there clinical trials available for relapsed or high-risk patients?

Israel offers numerous clinical trials for relapsed and high-risk myeloma patients. Major centers utilize advanced CAR T-cell therapies and bispecific antibodies. These trials provide access to innovative treatments for those not responding to standard care. Facilities like Sheba Medical Center are global leaders in immunotherapy research.

Therapy focus: Trials prioritize dual-target CAR T-cells and combination drug regimens.
Leading institutions: JCI-accredited centers in Tel Aviv, Ramat Gan, and Jerusalem.
Specialized expertise: Doctors like Dr. Ron Ram perform hundreds of stem cell transplants.
Quality standards: Facilities rank among Newsweek World's Best Hospitals for consecutive years.

Bookimed Expert Insight: Israeli oncology centers like Sourasky and Sheba have massive patient volumes, exceeding 1,800,000 yearly. This high throughput accelerates trial enrollment and data collection. Patients benefit from a 90% success rate in general oncology at specialized Tel Aviv facilities. Clinicians often combine research with practical care, as seen by their rankings in the global top 10 for consecutive years.

Patient Consensus: Patients value the direct access to Nobel-prize-winning expertise and latest CAR-T protocols. Many emphasize that coordinate Care in Israel feels exceptionally personalized despite the massive size of the hospitals.

How long should I expect to stay in Israel for treatment?

Myeloma treatment in Israel typically requires a stay of 1 to 8 weeks depending on the protocol. Diagnostics usually conclude within 5 days. Complex therapies like CAR-T cell infusion require intensive monitoring for approximately 8 weeks. Standard chemo-immunotherapy cycles often allow patients to return home between sessions.

Diagnostics phase: Diagnostic programs at JCI-accredited centers generally take 1 to 5 days.
Treatment duration: Basic oncology protocols often involve 1 to 3 weeks for initial stabilization.
CAR-T monitoring: Sheba Medical Center requires about 8 weeks for CAR-T cell therapy observation.
Follow-up care: Clinics recommend staying nearby for several days post-discharge for medical reviews.

Bookimed Expert Insight: Israeli oncology centers like Sourasky or Sheba often fast-track international cases to avoid local wait times. While residents may wait significantly longer for elective care, international patients typically begin specialized diagnostics immediately upon arrival. This efficiency is critical for myeloma patients who require rapid intervention after a diagnosis is confirmed.

Patient Consensus: Patients note that staying in a nearby hotel rather than the hospital for follow-up days makes the recovery process much more comfortable and less stressful.